CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update.

MLA

Mendel, Arielle, et al. “CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-Associated Vasculitis: 2020 Update.” Journal of Rheumatology, vol. 48, no. 4, Apr. 2021, pp. 555–66. EBSCOhost, https://doi.org/10.3899/jrheum.200721.

APA

Mendel, A., Ennis, D., Go, E., Bakowsky, V., Baldwin, C., Benseler, S. M., Cabral, D. A., Carette, S., Clements-Baker, M., Clifford, A. H., Tervaert, J. W. C., Cox, G., Dehghan, N., Dipchand, C., Dhindsa, N., Famorca, L., Fifi-Mah, A., Garner, S., Girard, L.-P., & Lessard, C. (2021). CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update. Journal of Rheumatology, 48(4), 555–566. https://doi.org/10.3899/jrheum.200721

Chicago

Mendel, Arielle, Daniel Ennis, Ellen Go, Volodko Bakowsky, Corisande Baldwin, Susanne M. Benseler, David A. Cabral, et al. 2021. “CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-Associated Vasculitis: 2020 Update.” Journal of Rheumatology 48 (4): 555–66. doi:10.3899/jrheum.200721.